Company: LRHC
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112656
Chunk: 283

Company: La Rosa Holdings Corp.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 2
Chunk 283
---
 defined therein). The Token Right can be exercised at any time beginning on the date
that is the sixty (60) day anniversary of the issuance date of the Token Right and ending on the ten (10) year anniversary of the issuance
date of the Token Right.

The Company has also agreed to use reasonable
efforts to obtain stockholder approval (the “Stockholder Approval”) within thirty (30) days of the Initial Closing Date (as
defined in the Notes) for the issuance of the shares of common stock issuable pursuant to the Notes in accordance with Nasdaq Listing
Rules, the approval of an amendment to the Amended and Restated Articles of Incorporation of the Company, as amended (the “Articles
of Incorporation”) to effect a reverse stock split at such later date and at ratio to be determined by the Company’s Board
of Directors, and the approval of an amendment to the Articles of Incorporation to permit the redemption of the Company’s Series
X Super Voting Preferred Stock, par value $0.0001 per share (the “Series X Preferred Stock”). On November 12, 2025, the stockholders
holding majority of the voting power of the Company provided the Stockholder Approval by written consent in lieu of having a stockholders
meeting. Such Stockholder Approval will become effective 20 days after the Company commences mailing of a definitive information statement
on Schedule 14C to stockholders of record as of the close of business on November 12, 2025.

In connection with the Purchase Agreement, on
November 12, 2025, the Company also entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with
the Investors, pursuant to which the Company agreed to file a registration statement on Form S-1 with the Securities and Exchange Commission
(the “SEC”) to register the resale of all of the Conversion Shares and shares of common stock otherwise issuable pursuant
to the Notes.

A.G.P./Alliance Global Partners served as placement
agent in connection with the offering and will receive cash compensation not exceeding 7% of the gross proceeds of each Closing.

In connection with the Purchase Agreement, on
November 12, 2025, the Company and Mr. La Rosa entered into a redemption agreement (“Redemption Agreement”), pursuant to which,
on the Initial Closing Date the Company will redeem and immediately cancel and return to the status of “blank check” preferred
stock of the Company, a number of Mr. La Rosa’s shares of Series X